Dr. Lader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Mary's Ave
Suite 3
Kingston, NY 12401Phone+1 845-339-3663Fax+1 845-339-3629
Education & Training
- NYU Grossman School of MedicineFellowship, Cardiovascular Disease, 1982 - 1983
- University at BuffaloResidency, Internal Medicine, 1978 - 1981
- New York University School of MedicineClass of 1978
Certifications & Licensure
- NY State Medical License 1979 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- In ASCVD, an inclisiran-first strategy reduced LDL-C levels and statin discontinuation at 330 d.Ellis Lader
Annals of Internal Medicine. 2024-08-01 - After PCI and 6 to 18 mo of DAPT, clopidogrel reduced a composite of clinical events vs. aspirin at 6 y.Ellis W Lader
Annals of Internal Medicine. 2023-04-01 - In rheumatic heart disease-associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 y.Ellis W Lader
Annals of Internal Medicine. 2023-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: